Table 1.
Function | Disease | Exo | Effect | Reference |
Anti-inflammatory | RA | miR-135b | Promote chondrocyte proliferation | [18] |
miR-150-5p | Alleviate abnormal vascular proliferation | [18] | ||
Liver injury | Hepatocyte growth factor | Promote hepatocyte growth | [20] | |
COVID-19 | Exo- Liposome | Inhibit viral intracellular pathways and suppress inflammatory cytokine storm | [32,33] | |
Hypersensitivity | ovalbumin | Modulate the immune response | [36] | |
miR-146a-5p | Alleviate airway hyperresponsiveness | [38] | ||
Tissue repair | Heart disease | miR-24-3p | Reduce myocardial infarction | [54] |
miR-183-5p | Inhibit cardiomyocyte aging | [56] | ||
miR-146a-5p | Attenuate drug-induced oxidative stress in cardiomyocytes | [59] | ||
IONP-Exo | Reduce cardiomyocyte apoptosis and fibrosis | [64] | ||
Kidney damage | miR-186-5p | Inhibit ECM protein accumulation and epithelial-mesenchymal transition and attenuates renal fibrosis | [70] | |
miR-146b | Reduce IL-1 receptor-related kinase expression and inhibit NF-κB activity | [73] | ||
Osteoarthritis | VEGF | Enhance angiogenesis | [78] | |
CLEC11A | Enhance bone formation and reduce bone resorption | [79] | ||
CD73 | mediate cartilage repair and regeneration | [80] | ||
miRNA-128-3p | Target inhibition of Smad5 attenuates cellular osteogenic differentiation and fracture healing in vivo | [83] | ||
Anti-tumor factor vector | CRC | miR-16-5p | Down-regulate integrin α2 and inhibit cancer cell progression | [84] |
miR-326 | Inhibit NF-κB and thus reduce immune factors | [86] | ||
miR-1246 | Restore Th17/Treg balance and reduce IBD | [88] | ||
HNSCC | miR-101-3p | Inhibit cancer cell proliferation and tumor growth | [93] | |
siRNA | Knockdown of Survivin gene to inhibit tumor growth | [95] | ||
Regeneration | AD | GDF-15 | Mitigate Aβ42-induced apoptosis and inflammation | [111] |
PD | peroxisome mRNA | Reduce neurotoxicity and neuroinflammation | [118] |
RA: rheumatoid arthritis; COVID-19: Coronavirus disease 2019; IONP: iron oxide nanoparticles; ECM: extracellular matrix; IL: interleukin; CRC: colorectal cancer; IBD: inflammatory bowel disease; HNSCC: head and neck squamous cell carcinoma; AD: Alzheimer's disease; GDF: growth differentiation factor 15; PD: Parkinson's disease.